Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$0.41 - $1.4 $10,992 - $37,535
26,811 Added 8.87%
329,123 $141,000
Q1 2023

May 12, 2023

BUY
$1.05 - $2.04 $1,207 - $2,346
1,150 Added 0.38%
302,312 $393,000
Q4 2022

Feb 13, 2023

BUY
$0.82 - $1.48 $483 - $873
590 Added 0.2%
301,162 $439,000
Q3 2022

Nov 14, 2022

SELL
$1.76 - $3.03 $10,076 - $17,346
-5,725 Reduced 1.87%
300,572 $562,000
Q2 2022

Aug 12, 2022

BUY
$2.29 - $3.86 $7,463 - $12,579
3,259 Added 1.08%
306,297 $714,000
Q1 2022

May 12, 2022

SELL
$2.95 - $4.41 $277 - $414
-94 Reduced 0.03%
303,038 $1.19 Million
Q4 2021

Feb 10, 2022

BUY
$4.03 - $8.15 $463 - $937
115 Added 0.04%
303,132 $1.26 Million
Q3 2021

Nov 09, 2021

SELL
$7.48 - $10.17 $833,578 - $1.13 Million
-111,441 Reduced 26.89%
303,017 $2.47 Million
Q2 2021

Aug 11, 2021

BUY
$7.8 - $17.35 $3.23 Million - $7.19 Million
414,458 New
414,458 $4.17 Million

About Novan, Inc.


  • Ticker NOVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,281,600
  • Market Cap $638K
  • Description
  • Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...
More about NOVN
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.